Alliance Pharma PLC Block Listing Six Monthly Return (3666Y)
January 02 2024 - 5:51AM
UK Regulatory
TIDMAPH
RNS Number : 3666Y
Alliance Pharma PLC
02 January 2024
For immediate release 02 January 2024
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Block Listing Six Monthly Return
Name of applicant: ALLIANCE PHARMA PLC
Names of schemes: a) The Alliance Pharma plc Approved Share Option Plan 2005
b) The Alliance Pharma plc Share Option Plan 2006
c) The Alliance Pharma plc Company Share Option Plan 2015
d) The Alliance Pharma plc Long-Term Incentive Plan 2019
---------------------------------------------------------------
Period of return: From: 28 June 2023 To: 31 December 2023
---------------------- ----------------------- ------- -----------------------------
Number of securities originally admitted at date of 25,000,000 ordinary shares of 1p each
admission: 28 June 2017
---------------------------------------------------------------
Balance of unallotted securities under schemes from a) 57,922
previous return: b) 2,487,746
c) 9,572,622
d) 1,341,116
---------------------------------------------------------------
Plus: The amount by which the block schemes have a) Nil
been increased since the date of the last b) Nil
return (if any increase has been applied for): c) Nil
d) Nil
---------------------------------------------------------------
Less: Number of securities issued/allotted under a) 0
schemes during period: b) 14,239
c) 0
d) 225,618
---------------------------------------------------------------
Equals: Balance under schemes not yet a) 57,922
issued/allotted at end of period: b) 2,473,507
c) 9,572,622
d) 1,115,498
---------------------------------------------------------------
Name of contact: Chris Chrysanthou, Company Secretary
Telephone number of contact: Tel. +44 (0)1249 705166
-------------------------------------
For further information:
Alliance Pharma plc + 44 (0)1249 466966
Head of Investor Relations: Cora McCallum + 44 (0)1249 705168
ir@allianceph.com
+ 44 (0)20 7466
Buchanan 5000
Mark Court / Sophie Wills
alliancepharma@buchanan.uk.com
Deutsche Numis (Nominated Adviser and + 44 (0)20 7260
Joint Broker ) 1000
Nominated Adviser: Freddie Barnfield /
Duncan Monteith / Sher Shah
+ 44 (0)20 7597
Investec Bank plc (Joint Broker) 5970
Patrick Robb / Maria Gomez de Olea
About Alliance
Alliance Pharma plc (AIM: APH) is a growing consumer healthcare
company . Our purpose is to empower people to make a positive
difference to their health and wellbeing by making our trusted and
proven brands available around the world.
We deliver organic growth through investing in our priority
brands and channels, in related innovation, and through selective
geographic expansion to increase the reach of our brands.
Periodically, we may look to enhance our organic growth through
selective, complementary acquisitions .
Headquartered in the UK, the Group employs around 285 people
based in locations across Europe, North America, and the Asia
Pacific region. By outsourcing our manufacturing and logistics we
remain asset-light and focused on maximising the value we can
bring, both to our stakeholders and to our brands. For more
information on Alliance, please visit our website :
www.alliancepharmaceuticals.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BLRUUSRRSNUARAR
(END) Dow Jones Newswires
January 02, 2024 05:51 ET (10:51 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Sep 2024 to Oct 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Oct 2023 to Oct 2024